Asia Pacific Helicobacter Pylori (H. pylori) Non-invasive Testing Market Forecast to 2028 – COVID

Asia Pacific Helicobacter Pylori (H. pylori) Non-invasive Testing Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Test Type (Serology, Stool Antigen, and Urea Breath), Test Method (Laboratory Based and Point-of-Care), and End User (Hospitals, Clinics, and Diagnostic Laboratories)

Report Code : BMIRE00027537 | Region : Asia Pacific | Industry : Medical Device | Published Date : 23/Nov/2022

The helicobacter pylori (H. pylori) non-invasive testing market in Asia Pacific is expected to grow from US$ 143.04 million in 2022 to US$ 201.37 million by 2028; it is estimated to grow at a CAGR of 5.9% from 2022 to 2028.

Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori

Diagnosis of H. pylori infection is performed by invasive (endoscopy and endoscopic biopsy for histopathology, culture, and rapid urease test) and non-invasive (urea breath tests, stool antigen test, and serological tests) methods. The diagnostic decisions are based on the prevalence of H. pylori infection and age-related gastric cancer incidence. For instance, non-invasive techniques are preferred mostly where gastric cancer incidence is low. In contrast, endoscopy is recommended for patients who have a high probability of getting gastric cancer, such as patients who are above 60 years of age or younger patients in a few Asia Pacific countries, or patients with a family history of gastric cancer or geographic regions with a high incidence of gastric cancer.

For instance, the Japanese Society for Helicobacter suggests to patients that the diagnosis of H. pylori infection should be performed using at least one invasive and non-invasive method. However, increased accuracy is obtained by using multiple diagnostic tests. Although these tests have high accuracy, the endoscopy-based diagnostic methods are not recommended for screening purposes, mainly due to their invasiveness, high cost, and unavailability. Thus, the growing awareness spread by governments for proper diagnosis has led to the advent of breakthrough techniques, expected to fuel the market's growth. Further, in 2020, RedHill Biopharma launched a nationwide H. pylori disease state educational field led by its sales force. The launch is intended to provide greater awareness to healthcare professionals regarding the risk of H. pylori infection and the growing resistance of H. pylori to standard care of antibiotics, leading to 25-40% failure of current therapies.

Market Overview

Asia Pacific is the fastest-growing market for Helicobacter pylori (H. pylori) non-invasive testing. The Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is segmented into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. Asia Pacific accounted for over 22.76% of the global Helicobacter pylori (H. pylori) non-invasive testing market in 2021 due to the rising geriatric population and high prevalence of H. pylori and gastric cancer cases. Therefore, the region holds huge potential for the market players to grow during the forecast period. China is a developing country in Asia Pacific with a well-established healthcare system and a fast-growing pharmaceutical industry. China is home to various medical, pharmaceutical, and biotechnology product manufacturing companies operating in the global market. These pharmaceuticals and biotechnology companies are involved in the development of various testing kits and devices for the dectection of Helicobacter pylori owing to the high prevalence of various H. pylori infections and gastric (stomach) cancer cases, which boosts the growth of the Helicobacter pylori non-invasive testing market.

The rising geriatric population is expected to offer vital growth opportunities for the Helicobacter pylori (H. pylori) non-invasive testing market in the coming years. However, the prevalence of Helicobacter pylori infection is significant in all ages; however, the geriatric population is likely to diagnose with gastric cancer and infections that can lead to serious illness and other medical emergencies. According to World Health Organization, in China, in 2019, there were ~254 million people of age 60 and older and ~176 million people of age 65 and over. It is estimated that ~402 million people (28% of the total population) in China will be over the age of 60 by 2040, which will create an opportunity for the use of various H. pylori testing kits, leading to the market growth in the coming years.

Asia Pacific Helicobacter Pylori (H. pylori) Non-invasive Testing Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Helicobacter Pylori (H. pylori) Non-invasive Testing Market Segmentation

The Asia Pacific helicobacter pylori (H. pylori) non-invasive testing market is segmented on test type, test method, end user, and country.

Based on test type, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market. Based on test method, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022. Based on end user, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022. Based on country, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is segmented into Australia, China, India, Japan, South Korea, the Rest of Asia Pacific. Further, China dominated the market in 2022. Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc. are the leading companies operating in the helicobacter pylori (H. pylori) non-invasive testing market in Asia Pacific.

At 5.9% CAGR, the Asia Pacific Helicobacter Pylori (H. pylori) Non-invasive Testing Market is speculated to be worth US$ 201.37 Million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Asia Pacific helicobacter pylori (H. pylori) non-invasive testing market was valued at US$ 143.04 million in 2022 and is expected to reach US$ 201.37 million by 2028, registering an annual growth rate of 5.9% from 2022 to 2028. Rising investments in pharma sector and new product launches & FDA approvals for noninvasive tests are the critical factors attributed to the market expansion.

The encouraging response of non-invasive tests in the global market has further propelled market research and development activities. The key players in the global Helicobacter pylori non-invasive test market are Meridian Bioscience, DiaSporin, Exalenz Bioscience, Biomerica, Alere, Sekisui Diagnostics, and others. The pharmaceutical giants have also adopted strategic alliances such as collaboration, partnerships, or acquisitions to maintain a strategic edge in the global market.

In 2020, Meridian Bioscience entered a definitive agreement to acquire Exalenz for about US$ 49 million. Under the terms of the agreement, Meridian will be adding Exalenz's flagship BreathID® Breath Test Systems, a urea breath test platform for the detection of H. pylori.

In 2018, DiaSorin entered into a strategic collaboration with Meridian Bioscience to commercialize DiaSorin's FDA-cleared H. pylori stool antigen test to detect H. pylori for use on its automated LIAISON platform under the Meridian brand name.

On the contrary, very low diagnosis rate hurdles the growth of Asia Pacific helicobacter pylori (H. pylori) non-invasive testing market.

Based on test type, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is segmented into serology, stool antigen, and urea breathe. In 2022, the urea breath segment is expected to hold the largest share of the market in 2022 with a share of 44.9%, amassing US$ 9 64.23 million. It is projected to garner US$ 92.41 million by 2028 to expand at 6.3% CAGR during 2022–2028. Based on test method, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is bifurcated into laboratory based and point of care. The laboratory based segment is expected to hold a larger share of the market in 2022 with a share of 75.4%, amassing US$ 107.92 million. It is projected to garner US$ 153.49 million by 2028 to expand at 6.0% CAGR during 2022–2028. Based on end user, the Asia Pacific Helicobacter pylori (H. pylori) non-invasive testing market is segmented into hospitals, clinics, and diagnostic laboratories. The diagnostic laboratories segment is expected to hold the largest share of the market in 2022 with a share of 58.7%, amassing US$ 83.90 million. It is projected to garner US$ 119.96 million by 2028 to expand at 6.1% CAGR during 2022–2028. Our regional analysis states that China captured 30.7% market share in 2022. It was assessed at US$ 43.88 million in 2022 and is likely to hit US$ 62.73 million by 2028, exhibiting a CAGR of 6.1% during the forecast period.

Key players dominating the Asia Pacific helicobacter pylori (H. pylori) non-invasive testing market are Abbott Laboratories; Bio-Rad Laboratories Inc.; CerTest Biotec; Coris BioConcept; DiaSorin S.p.A.; Meridian Bioscience Inc.; QuidelOrtho Corporation; Sekisui Diagnostics; Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd; and Thermo Fisher Scientific Inc.

Below are mentioned a few key market developments by major players:

In Dec 2021, Thermo Fisher Scientific Inc. announced that it has completed its acquisition of PPD, Inc. (Nasdaq: PPD), a leading global provider of clinical research services to the biopharma and biotech industry, for $17.4 billion. In April 2020, Meridian Bioscience, Inc. has completed the acquisition of Exalenz Bioscience Ltd., the Modiin, Israel-based provider of the BreathID Breath Test Systems, a urea breath test platform for the detection of Helicobacter pylori.

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – By Test Type

1.3.2 APAC Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By Test Method

1.3.3 APAC Helicobacter Pylori (H. pylori) Non-invasive Testing Market – By End User

1.3.4 APAC Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Helicobacter Pylori (H. pylori ) Non-invasive Testing Market – Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Helicobacter Pylori (H. pylori ) Non-Invasive Testing Market – Key Industry Dynamics

5.1 Key Market Drivers

5.1.1 Increasing prevalence of H. pylori bacterial infection

5.1.2 New Product Launches & FDA Approvals for Noninvasive Tests

5.1.3 Spreading Awareness Among Individuals Regarding Diagnosis of H. pylori

5.1.4 Rise in Investments by Pharmaceutical Companies

5.2 Key Market Restraints

5.2.1 Low Diagnosis Rate

5.3 Key Market Opportunities

5.3.1 Increasing Number of Conferences and Events for Research

5.3.2 Introduction of Artificial Intelligence

5.4 Future Trends

5.4.1 Increasing Use of Home-Based POC Devices

5.4.2 Diagnosis for Resistance

5.5 Impact Analysis

6. Helicobacter pylori (H. pylori ) Non-Invasive Testing Market– APAC Analysis

6.1 APAC Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue Forecast and Analysis

7. APAC Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis– by Test Type

7.1 Overview

7.2 APAC Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By Test Type 2022 & 2028 (%)

7.3 Serology Test

7.3.1 Overview

7.3.2 APAC Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)

7.4 Stool Antigen Test

7.4.1 Overview

7.4.2 APAC Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)

7.5 Urea Breath Test

7.5.1 Overview

7.5.2 APAC Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)

8. APAC Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Analysis– by Test Method

8.1 Overview

8.2 APAC Helicobacter pylori (H. pylori) Non-invasive Testing Market, By Test Method 2022 & 2028 (%)

8.3 Laboratory Based Tests

8.3.1 Overview

8.3.2 APAC Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)

8.4 Point Of Care Tests

8.4.1 Overview

8.4.2 APAC Point of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)

9. APAC Helicobacter pylori (H. pylori ) Non-invasive Testing Market Analysis– by End User

9.1 Overview

9.2 APAC Helicobacter pylori (H. pylori ) Non-invasive Testing Market, By End User 2018 & 2028 (%)

9.3 Hospitals

9.3.1 Overview

9.3.2 APAC Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)

9.4 Clinics

9.4.1 Overview

9.4.2 APAC Clinics Market Revenue and Forecasts to 2028 (US$ Mn)

9.5 Diagnostic Laboratories

9.5.1 Overview

9.5.2 APAC Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

10. APAC Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Revenue and Forecasts to 2028 – Country Analysis

10.1 Overview

10.1.1 Asia Pacific: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028, By Country, 2022 & 2028 (%)

10.1.1.1 China: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 China: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.1.3 China: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)

10.1.1.1.4 China: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)

10.1.1.1.5 China: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)

10.1.1.2 Japan: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 Japan: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.2.3 Japan: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)

10.1.1.2.4 Japan: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)

10.1.1.2.5 Japan: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)

10.1.1.3 India Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 India: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.3.3 India: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)

10.1.1.3.4 India: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)

10.1.1.3.5 India: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)

10.1.1.4 South Korea: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 South Korea: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.4.3 South Korea: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)

10.1.1.4.4 South Korea: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)

10.1.1.4.5 South Korea: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)

10.1.1.5 Australia: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 Australia: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.1.5.3 Australia: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)

10.1.1.5.4 Australia: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)

10.1.1.5.5 Australia: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)

10.1.1.6 Rest of Asia Pacific: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Asia Pacific: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3 Rest of Asia Pacific: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By Test Type – 2019–2028 (US$ Million)

10.1.1.6.4 Rest of Asia Pacific: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, by Test Method – 2019–2028 (US$ Million)

10.1.1.6.5 Rest of Asia Pacific: Helicobacter pylori (H. pylori ) Non-Invasive Testing Market, By End User – 2019–2028 (US$ Million)

11. Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market–Industry Landscape

11.1 Overview

11.2 Growth Strategies in the Helicobacter Pylori (H. Pylori ) Non-Invasive Testing Market

11.3 Inorganic Growth Strategies

11.3.1 Overview

11.4 Organic Growth Strategies

11.4.1 Overview

12. Company Profile

12.1 DiaSorin S.p.A.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Meridian Bioscience, Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 QuidelOrtho Corporation

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Abbott Laboratories

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Thermo Fisher Scientific Inc.

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 CerTest Biotec

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Sekisui Diagnostics

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Coris BioConcept

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd.

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Bio-Rad Laboratories, Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES.

Table 1. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).

Table 2. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)

Table 3. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 4. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).

Table 5. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)

Table 6. Japan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).

Table 8. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)

Table 9. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 10. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).

Table 11. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)

Table 12. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 13. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).

Table 14. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)

Table 15. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 16. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Type – Revenue and Forecast to 2028 (US$ Million).

Table 17. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by Test Method – Revenue and Forecast to 2028 (US$ Million)

Table 18. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 19. Recent Inorganic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market

Table 20. Recent Organic Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market

Table 21. Glossary of Terms

LIST OF FIGURES.

Figure 1. APAC Helicobacter Pylori (H. pylori ) Non-invasive Testing Market Segmentation

Figure 2. APAC Helicobacter Pylori (H. pylori ) Non-invasive Testing Market, By Country

Figure 3. APAC Helicobacter Pylori (H. pylori) Non-invasive Testing Market Overview

Figure 4. Urea Breath Segment Held Largest Share of Test Type Segment in APAC Helicobacter Pylori (H. pylori) Non-invasive Testing Market

Figure 5. Australia is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. APAC: PEST Analysis

Figure 7. Experts Opinion

Figure 8. APAC Helicobacter pylori Non-Invasive Testing Market Impact Analysis of Driver and Restraints

Figure 9. APAC Helicobacter pylori (H. pylori) Non-Invasive Testing Market– Revenue Forecast and Analysis – 2020 - 2028

Figure 10. APAC Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Type 2022 & 2028 (%)

Figure 11. APAC Serology Test Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 12. APAC Stool Antigen Test Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 13. APAC Urea Breath Test Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 14. APAC Helicobacter pylori (H. pylori) Noninvasive Testing Market, by Test Method 2022 & 2028 (%)

Figure 15. APAC Laboratory Based Tests Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 16. APAC Point of Care Tests Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 17. APAC Helicobacter pylori (H. pylori) Noninvasive Testing Market, by End User 2018 & 2028 (%)

Figure 18. APAC Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 19. APAC Clinics Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 20. APAC Diagnostic Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 21. Asia Pacific Helicobacter pylori (H. pylori) Non-Invasive Testing Market Overview, by Country (2022)

Figure 22. Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028, By Country, 2022 & 2028 (%)

Figure 23. China: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24. apan: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 25. India: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 26. South Korea: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 27. Australia: Helicobacter pylori (H. pylori) Non-Invasive Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28. Rest of Asia Pacific: Helicobacter pylori (H. pylori) Non-Invasive Testing Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29. Growth Strategies in the Helicobacter Pylori (H. Pylori) Non-Invasive Testing Market

The List of Companies - Asia Pacific Helicobacter Pylori (H. pylori) Non-invasive Testing Market

● Abbott Laboratories

● Bio-Rad Laboratories Inc.

● CerTest Biotec; Coris BioConcept

● Coris BioConcept

● DiaSorin S.p.A.

● Meridian Bioscience Inc.

● QuidelOrtho Corporation

● Sekisui Diagnostics

● Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd

● Thermo Fisher Scientific Inc.

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific helicobacter pylori (H. pylori) non-invasive testing market

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific helicobacter pylori (H. pylori) non-invasive testing market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the helicobacter pylori (H. pylori) non-invasive testing market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

TOP